Nearly two years after submitting its MiniMed 780G insulin delivery system to the FDA for clearance, Medtronic is still awaiting the agency’s nod—though not for a lack of evidence to back the ...

Medtronic came out with two pieces of news yesterday around its connected diabetes efforts: an FDA clearance for a hybrid closed loop insulin delivery system and the first test cohort of its Sugar.IQ ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the ...

The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the Medtronic MiniMed 780G system for people with type 1 diabetes aged 7 years and older. The ...

Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring. The Medtronic 780G system encompasses ...

Credit: Getty Images. The first shipments of the MiniMed 780G system are expected this summer with preorders beginning on May 15, 2023. The Food and Drug Administration (FDA) has approved the ...

The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic. The FDA has approved Medtronic’s MiniMed 780G system with Guardian 4 ...

Medtronic plc MDT announced one-year data from the ADAPT study -- the first multi-national randomized controlled study evaluating the performance of the MiniMed 780G advanced hybrid closed loop ...